ACE |
angiotensin II converting enzyme |
Akt |
Protein Kinase B |
ANP |
atrial natriuretic peptide |
BNP |
brain natriuretic peptide |
CD |
conduction defect |
CMT2B1 |
Charcot‒Marie‒Tooth disease type 2B1 |
CRISPR/Cas9 |
Clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 |
Cx 40/43 |
Connexin 40/43 |
DCM |
Dilated Cardiomyopathy |
DMD |
Duchenne Muscular Dystrophy |
EDMD |
Emery‒Dreifuss Muscular Dystrophy |
ERK 1/2 |
Extracellular signal-regulated kinases 1/2 |
FHL2 |
four-and-a half LIM protein-2 |
FPLD2 |
Familial partial lipodystrophy Dunnigan-type 2 |
Hf1b/Sp4 |
Transcription factor Sp4 |
HGPS |
Hutchison Gilford Progeria Syndrome |
hpf |
hours post-fertilization |
iPSCs |
induced pluripotent stem cells |
JNK |
c-Jun N-terminal kinases |
Keap1 |
Kelch-like ECH-associated protein 1 |
LAP2 |
Lamina-associated polypeptide 2 |
L-CMD |
LMNA-related Congenital Muscular Dystrophy |
LGMD1B |
1B Limb-girdle muscular dystrophy |
MAPK |
Mitogen-activated protein kinase |
MEFs |
Mouse embryonic fibroblasts |
MEK 1/2 |
Dual-specificity mitogen-activated protein kinase kinase ½ |
MO |
Morpholino |
mTor |
mechanistic target of rapamycin |
Myh6 |
myosin heavy-chain alpha |
Myh7 |
myosin heavy-chain beta |
NAT10 |
N-Acetyltransferase 10 |
NFκB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
NPCs |
Nuclear pore complexes |
Nppb |
Natriuretic peptide B |
Nrf2 |
Nuclear factor erythroid-2-related factor 2 |
Nup153/154 |
Nucleoporin 153/154 |
p62/SQSTM1 |
Sequestosome-1 (ubiquitin-binding protein p62) |
PCNA |
Proliferating cell nuclear antigen |
PPAR-gamma |
Peroxisome proliferator-activated receptors gamma |
Smad 2/3 |
Mothers against decapentaplegic homolog 2/3 |
SREBF-1 |
Sterol regulatory element binding transcription factor 1 |
SRF |
Serum response factor |
SUMO1/2 |
Small ubiquitin-related modifier 1/2 |
syne1 |
Spectrin repeat-containing nuclear envelope protein 1 |
TF |
Transcription factor |
TGF-β |
Transforming growth factor beta |
WNT |
Wingless/Integrated |